Pharmaceutical composition for preventing or treating cancer

CN114867482BActive Publication Date: 2024-12-31INTEGRITY BIOTECHNOLOGY CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CN202080085117.8
Authority / Receiving Office: CN · China
Patent Type: Patents(China)
Current Assignee / Owner
Priority Date: 2019-12-13
Filing Date: 2020-12-14
Publication Date: 2024-12-31
Estimated Expiration: 2040-12-14

Application Information

Patent Timeline

13 Dec 2019

Priority

14 Dec 2020

Application

CN202080085117.8

31 Dec 2024

Publication

CN114867482B

IPC: A61K31/575; A61K31/4184; A61K31/4985; A61P35/00; A23L33/10

CPC: A23L33/10; A61K31/4184; A61K31/575; A61P35/00; A61K31/355; A61K31/202; A61K2300/00; A61K31/4985

Inventors: 延星燦

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure CN114867482B_ABST

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating cancer, comprising UDCA and a benzimidazole-based compound, which is expected to have an excellent anticancer effect as a mixture and have the advantage of having fewer side effects because of lower cytotoxicity compared with anticancer agents used for existing treatments.

Need to check novelty before this filing date? Find Prior Art